Patents/Assignees

LYELL IMMUNOPHARMA, Inc.

5 patents in portfolio

US12365871utility2025
Methods for Culturing Cells
0 cites
US12270032utility2025
Codon-optimized Nucleotide Sequences Encoding an AP-1 Transcription Factor
0 cites
US12144827utility2024
ROR1 Targeting Chimeric Antigen Receptor
0 cites
US12091682utility2024
Methods for Making, Compositions Comprising, and Methods of Using Rejuvenated T Cells
0 cites
US12054531utility2024
Recombinant Cell Surface Markers
0 cites